Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 153

1.

Novel biomarkers for primary biliary cholangitis to improve diagnosis and understand underlying regulatory mechanisms.

Bombaci M, Pesce E, Torri A, Carpi D, Crosti M, Lanzafame M, Cordiglieri C, Sinisi A, Moro M, Bernuzzi F, Gerussi A, Geginat J, Muratori L, Terracciano LM, Invernizzi P, Abrignani S, Grifantini R.

Liver Int. 2019 Apr 29. doi: 10.1111/liv.14128. [Epub ahead of print]

PMID:
31033124
2.

The Translational Machinery of Human CD4+ T Cells Is Poised for Activation and Controls the Switch from Quiescence to Metabolic Remodeling.

Ricciardi S, Manfrini N, Alfieri R, Calamita P, Crosti MC, Gallo S, Müller R, Pagani M, Abrignani S, Biffo S.

Cell Metab. 2018 Dec 4;28(6):961. doi: 10.1016/j.cmet.2018.09.010. No abstract available.

3.

Eomesodermin controls a unique differentiation program in human IL-10 and IFN-γ coproducing regulatory T cells.

Gruarin P, Maglie S, De Simone M, Häringer B, Vasco C, Ranzani V, Bosotti R, Noddings JS, Larghi P, Facciotti F, Sarnicola ML, Martinovic M, Crosti M, Moro M, Rossi RL, Bernardo ME, Caprioli F, Locatelli F, Rossetti G, Abrignani S, Pagani M, Geginat J.

Eur J Immunol. 2019 Jan;49(1):96-111. doi: 10.1002/eji.201847722. Epub 2018 Nov 29.

PMID:
30431161
4.

The Translational Machinery of Human CD4+ T Cells Is Poised for Activation and Controls the Switch from Quiescence to Metabolic Remodeling.

Ricciardi S, Manfrini N, Alfieri R, Calamita P, Crosti MC, Gallo S, Müller R, Pagani M, Abrignani S, Biffo S.

Cell Metab. 2018 Dec 4;28(6):895-906.e5. doi: 10.1016/j.cmet.2018.08.009. Epub 2018 Sep 6. Erratum in: Cell Metab. 2018 Dec 4;28(6):961.

PMID:
30197303
5.

Exploring the links between cancer and placenta development.

Costanzo V, Bardelli A, Siena S, Abrignani S.

Open Biol. 2018 Jun;8(6). pii: 180081. doi: 10.1098/rsob.180081. Review.

6.

Intestinal IFN-γ-producing type 1 regulatory T cells coexpress CCR5 and programmed cell death protein 1 and downregulate IL-10 in the inflamed guts of patients with inflammatory bowel disease.

Alfen JS, Larghi P, Facciotti F, Gagliani N, Bosotti R, Paroni M, Maglie S, Gruarin P, Vasco CM, Ranzani V, Frusteri C, Iseppon A, Moro M, Crosti MC, Gatti S, Pagani M, Caprioli F, Abrignani S, Flavell RA, Geginat J.

J Allergy Clin Immunol. 2018 Nov;142(5):1537-1547.e8. doi: 10.1016/j.jaci.2017.12.984. Epub 2018 Jan 31.

7.

TCTN2: a novel tumor marker with oncogenic properties.

Cano-Rodriguez D, Campagnoli S, Grandi A, Parri M, Camilli E, Song C, Jin B, Lacombe A, Pierleoni A, Bombaci M, Cordiglieri C, Ruiters MH, Viale G, Terracciano L, Sarmientos P, Abrignani S, Grandi G, Pileri P, Rots MG, Grifantini R.

Oncotarget. 2017 Aug 24;8(56):95256-95269. doi: 10.18632/oncotarget.20438. eCollection 2017 Nov 10.

8.

Trans-splenic Embolization Plus Partial Splenic Embolization for Management of Variceal Bleeding Due to Left-Sided Portal Hypertension.

Gandini R, Merolla S, Chegai F, Abrignani S, Lenci I, Milana M, Angelico M.

Dig Dis Sci. 2018 Jan;63(1):264-267. doi: 10.1007/s10620-017-4863-9. Epub 2017 Nov 28. No abstract available.

PMID:
29185168
9.

Repression of miR-31 by BCL6 stabilizes the helper function of human follicular helper T cells.

Ripamonti A, Provasi E, Lorenzo M, De Simone M, Ranzani V, Vangelisti S, Curti S, Bonnal RJP, Pignataro L, Torretta S, Geginat J, Rossetti G, Pagani M, Abrignani S.

Proc Natl Acad Sci U S A. 2017 Nov 28;114(48):12797-12802. doi: 10.1073/pnas.1705364114. Epub 2017 Nov 13.

10.

Retrograde Endovascular Stenting of Preocclusive Celiac Artery Stenosis with Loop Technique Associated with Pancreaticoduodenal Artery Aneurysm Embolization.

Gandini R, Abrignani S, Perrone O, Lauretti DL, Merolla S, Scaggiante J, Vasili E, Floris R, Cioni R.

J Vasc Interv Radiol. 2017 Nov;28(11):1607-1609. doi: 10.1016/j.jvir.2017.06.035. No abstract available.

PMID:
29056196
11.

Lack of evidence for post-vaccine onset of autoimmune/lymphoproliferative disorders, during a nine-month follow-up in multiply vaccinated Italian military personnel.

Ferlito C, Barnaba V, Abrignani S, Bombaci M, Sette A, Sidney J, Biselli R, Tomao E, Cattaruzza MS, Germano V, Biondo MI, Salerno G, Lulli P, Caporuscio S, Picchianti Diamanti A, Falco M, Biselli V, Cardelli P, Autore A, Lucertini E, De Cesare DP, Peragallo MS, Lista F, Martire C, Salemi S, Nisini R, D'Amelio R.

Clin Immunol. 2017 Aug;181:60-66. doi: 10.1016/j.clim.2017.06.001. Epub 2017 Jun 15.

PMID:
28625884
12.

The Enigmatic Role of Viruses in Multiple Sclerosis: Molecular Mimicry or Disturbed Immune Surveillance?

Geginat J, Paroni M, Pagani M, Galimberti D, De Francesco R, Scarpini E, Abrignani S.

Trends Immunol. 2017 Jul;38(7):498-512. doi: 10.1016/j.it.2017.04.006. Epub 2017 May 23. Review.

PMID:
28549714
13.

Differences in serum and synovial CD4+ T cells and cytokine profiles to stratify patients with inflammatory osteoarthritis and rheumatoid arthritis.

Penatti A, Facciotti F, De Matteis R, Larghi P, Paroni M, Murgo A, De Lucia O, Pagani M, Pierannunzii L, Truzzi M, Ioan-Facsinay A, Abrignani S, Geginat J, Meroni PL.

Arthritis Res Ther. 2017 May 19;19(1):103. doi: 10.1186/s13075-017-1305-1.

14.

CombiROC: an interactive web tool for selecting accurate marker combinations of omics data.

Mazzara S, Rossi RL, Grifantini R, Donizetti S, Abrignani S, Bombaci M.

Sci Rep. 2017 Mar 30;7:45477. doi: 10.1038/srep45477.

15.

Recognition of viral and self-antigens by TH1 and TH1/TH17 central memory cells in patients with multiple sclerosis reveals distinct roles in immune surveillance and relapses.

Paroni M, Maltese V, De Simone M, Ranzani V, Larghi P, Fenoglio C, Pietroboni AM, De Riz MA, Crosti MC, Maglie S, Moro M, Caprioli F, Rossi R, Rossetti G, Galimberti D, Pagani M, Scarpini E, Abrignani S, Geginat J.

J Allergy Clin Immunol. 2017 Sep;140(3):797-808. doi: 10.1016/j.jaci.2016.11.045. Epub 2017 Feb 22.

PMID:
28237728
16.

Extracellular MicroRNA Signature of Human Helper T Cell Subsets in Health and Autoimmunity.

Torri A, Carpi D, Bulgheroni E, Crosti MC, Moro M, Gruarin P, Rossi RL, Rossetti G, Di Vizio D, Hoxha M, Bollati V, Gagliani C, Tacchetti C, Paroni M, Geginat J, Corti L, Venegoni L, Berti E, Pagani M, Matarese G, Abrignani S, de Candia P.

J Biol Chem. 2017 Feb 17;292(7):2903-2915. doi: 10.1074/jbc.M116.769893. Epub 2017 Jan 11.

17.

Endovascular Mechanical Thromboaspiration of Right Hepatic Arterial Thrombosis After Liver Transplantation.

Gandini R, Konda D, Toti L, Abrignani S, Merolla S, Tisone G, Floris R.

Cardiovasc Intervent Radiol. 2017 Apr;40(4):621-624. doi: 10.1007/s00270-016-1538-4. Epub 2016 Dec 28.

PMID:
28032131
18.

miR-17∼92 family clusters control iNKT cell ontogenesis via modulation of TGF-β signaling.

Fedeli M, Riba M, Garcia Manteiga JM, Tian L, Viganò V, Rossetti G, Pagani M, Xiao C, Liston A, Stupka E, Cittaro D, Abrignani S, Provero P, Dellabona P, Casorati G.

Proc Natl Acad Sci U S A. 2016 Dec 20;113(51):E8286-E8295. doi: 10.1073/pnas.1612024114. Epub 2016 Dec 5.

19.

Transcriptional Landscape of Human Tissue Lymphocytes Unveils Uniqueness of Tumor-Infiltrating T Regulatory Cells.

De Simone M, Arrigoni A, Rossetti G, Gruarin P, Ranzani V, Politano C, Bonnal RJP, Provasi E, Sarnicola ML, Panzeri I, Moro M, Crosti M, Mazzara S, Vaira V, Bosari S, Palleschi A, Santambrogio L, Bovo G, Zucchini N, Totis M, Gianotti L, Cesana G, Perego RA, Maroni N, Pisani Ceretti A, Opocher E, De Francesco R, Geginat J, Stunnenberg HG, Abrignani S, Pagani M.

Immunity. 2016 Nov 15;45(5):1135-1147. doi: 10.1016/j.immuni.2016.10.021.

20.

Next-Generation Sequencing Analysis of Long Noncoding RNAs in CD4+ T Cell Differentiation.

Ranzani V, Arrigoni A, Rossetti G, Panzeri I, Abrignani S, Bonnal RJ, Pagani M.

Methods Mol Biol. 2017;1514:173-185.

PMID:
27787801
21.

Reverse plasticity: TGF-β and IL-6 induce Th1-to-Th17-cell transdifferentiation in the gut.

Geginat J, Paroni M, Kastirr I, Larghi P, Pagani M, Abrignani S.

Eur J Immunol. 2016 Oct;46(10):2306-2310. doi: 10.1002/eji.201646618.

22.

Analysis RNA-seq and Noncoding RNA.

Arrigoni A, Ranzani V, Rossetti G, Panzeri I, Abrignani S, Bonnal RJ, Pagani M.

Methods Mol Biol. 2016;1480:125-35. doi: 10.1007/978-1-4939-6380-5_11.

PMID:
27659980
23.

Uncontrolled IL-17 Production by Intraepithelial Lymphocytes in a Case of non-IPEX Autoimmune Enteropathy.

Paroni M, Magarotto A, Tartari S, Nizzoli G, Larghi P, Ercoli G, Gianelli U, Pagani M, Elli L, Abrignani S, Conte D, Geginat J, Caprioli F.

Clin Transl Gastroenterol. 2016 Jul 14;7(7):e182. doi: 10.1038/ctg.2016.41.

24.

IL-10 promotes homeostatic proliferation of human CD8(+) memory T cells and, when produced by CD1c(+) DCs, shapes naive CD8(+) T-cell priming.

Nizzoli G, Larghi P, Paroni M, Crosti MC, Moro M, Neddermann P, Caprioli F, Pagani M, De Francesco R, Abrignani S, Geginat J.

Eur J Immunol. 2016 Jul;46(7):1622-32. doi: 10.1002/eji.201546136. Epub 2016 May 17.

25.

Intraprocedural Foot Embolization during In-Stent Restenosis Superficial Femoral Artery Recanalization: Plantar to Pedal Loop Aspiration Thrombectomy Technique Using the Penumbra MAX Catheter.

Gandini R, Merolla S, Chegai F, Pratesi G, Abrignani S, Loreni G, Pistolese CA, Pampana E.

J Vasc Interv Radiol. 2016 Apr;27(4):606-8. doi: 10.1016/j.jvir.2015.12.020. No abstract available.

PMID:
27013008
26.

The light and the dark sides of Interleukin-10 in immune-mediated diseases and cancer.

Geginat J, Larghi P, Paroni M, Nizzoli G, Penatti A, Pagani M, Gagliani N, Meroni P, Abrignani S, Flavell RA.

Cytokine Growth Factor Rev. 2016 Aug;30:87-93. doi: 10.1016/j.cytogfr.2016.02.003. Epub 2016 Mar 8. Review.

PMID:
26980675
27.

The circulating microRNome demonstrates distinct lymphocyte subset-dependent signatures.

de Candia P, Torri A, Fedeli M, Viganò V, Carpi D, Gorletta T, Casorati G, Pagani M, Dellabona P, Abrignani S.

Eur J Immunol. 2016 Mar;46(3):725-31. doi: 10.1002/eji.201545787. Epub 2015 Dec 29.

28.

Immunity to Pathogens Taught by Specialized Human Dendritic Cell Subsets.

Geginat J, Nizzoli G, Paroni M, Maglie S, Larghi P, Pascolo S, Abrignani S.

Front Immunol. 2015 Oct 13;6:527. doi: 10.3389/fimmu.2015.00527. eCollection 2015. Review.

29.

De novo transcriptome profiling of highly purified human lymphocytes primary cells.

Bonnal RJ, Ranzani V, Arrigoni A, Curti S, Panzeri I, Gruarin P, Abrignani S, Rossetti G, Pagani M.

Sci Data. 2015 Sep 29;2:150051. doi: 10.1038/sdata.2015.51. eCollection 2015.

30.

Hepatitis C Virus Deletion Mutants Are Found in Individuals Chronically Infected with Genotype 1 Hepatitis C Virus in Association with Age, High Viral Load and Liver Inflammatory Activity.

Cheroni C, Donnici L, Aghemo A, Balistreri F, Bianco A, Zanoni V, Pagani M, Soffredini R, D'Ambrosio R, Rumi MG, Colombo M, Abrignani S, Neddermann P, De Francesco R.

PLoS One. 2015 Sep 25;10(9):e0138546. doi: 10.1371/journal.pone.0138546. eCollection 2015.

31.

Signal Strength and Metabolic Requirements Control Cytokine-Induced Th17 Differentiation of Uncommitted Human T Cells.

Kastirr I, Crosti M, Maglie S, Paroni M, Steckel B, Moro M, Pagani M, Abrignani S, Geginat J.

J Immunol. 2015 Oct 15;195(8):3617-27. doi: 10.4049/jimmunol.1501016. Epub 2015 Sep 16.

32.

Two of Them Do It Better: Novel Serum Biomarkers Improve Autoimmune Hepatitis Diagnosis.

Mazzara S, Sinisi A, Cardaci A, Rossi RL, Muratori L, Abrignani S, Bombaci M.

PLoS One. 2015 Sep 16;10(9):e0137927. doi: 10.1371/journal.pone.0137927. eCollection 2015.

33.

IL-10-producing forkhead box protein 3-negative regulatory T cells inhibit B-cell responses and are involved in systemic lupus erythematosus.

Facciotti F, Gagliani N, Häringer B, Alfen JS, Penatti A, Maglie S, Paroni M, Iseppon A, Moro M, Crosti MC, Stölzel K, Romagnani C, Moroni G, Ingegnoli F, Torretta S, Pignataro L, Annoni A, Russo F, Pagani M, Abrignani S, Meroni P, Flavell R, Geginat J.

J Allergy Clin Immunol. 2016 Jan;137(1):318-321.e5. doi: 10.1016/j.jaci.2015.06.044. Epub 2015 Aug 25. No abstract available.

PMID:
26318071
34.

Normalization of circulating microRNA expression data obtained by quantitative real-time RT-PCR.

Marabita F, de Candia P, Torri A, Tegnér J, Abrignani S, Rossi RL.

Brief Bioinform. 2016 Mar;17(2):204-12. doi: 10.1093/bib/bbv056. Epub 2015 Aug 3.

35.

Gaps in knowledge and prospects for research of adjuvanted vaccines.

Seder R, Reed SG, O'Hagan D, Malyala P, D'Oro U, Laera D, Abrignani S, Cerundolo V, Steinman L, Bertholet S.

Vaccine. 2015 Jun 8;33 Suppl 2:B40-3. doi: 10.1016/j.vaccine.2015.03.057.

PMID:
26022566
36.

Long Intergenic Non-Coding RNAs: Novel Drivers of Human Lymphocyte Differentiation.

Panzeri I, Rossetti G, Abrignani S, Pagani M.

Front Immunol. 2015 Apr 15;6:175. doi: 10.3389/fimmu.2015.00175. eCollection 2015. Review.

37.

miRiadne: a web tool for consistent integration of miRNA nomenclature.

Bonnal RJ, Rossi RL, Carpi D, Ranzani V, Abrignani S, Pagani M.

Nucleic Acids Res. 2015 Jul 1;43(W1):W487-92. doi: 10.1093/nar/gkv381. Epub 2015 Apr 20.

38.

Inexplicable late type Ia endoleak associated with the low-profile Ovation endograft in a patient with favorable neck anatomy: treatment with transcaval coil embolization.

Gandini R, Del Giudice C, Abrignani S, Vasili E, Pampana E, Simonetti G.

J Endovasc Ther. 2015 Jun;22(3):426-30. doi: 10.1177/1526602815579898. Epub 2015 Apr 10.

PMID:
25862362
39.

The long intergenic noncoding RNA landscape of human lymphocytes highlights the regulation of T cell differentiation by linc-MAF-4.

Ranzani V, Rossetti G, Panzeri I, Arrigoni A, Bonnal RJ, Curti S, Gruarin P, Provasi E, Sugliano E, Marconi M, De Francesco R, Geginat J, Bodega B, Abrignani S, Pagani M.

Nat Immunol. 2015 Mar;16(3):318-325. doi: 10.1038/ni.3093. Epub 2015 Jan 26.

40.

Plasticity of human CD4 T cell subsets.

Geginat J, Paroni M, Maglie S, Alfen JS, Kastirr I, Gruarin P, De Simone M, Pagani M, Abrignani S.

Front Immunol. 2014 Dec 16;5:630. doi: 10.3389/fimmu.2014.00630. eCollection 2014. Review.

41.

Long-term results of drug-eluting balloon angioplasty for treatment of refractory recurrent carotid in-stent restenosis.

Gandini R, Del Giudice C, Da Ros V, Sallustio F, Altobelli S, D'Onofrio A, Abrignani S, Vasili E, Stanzione P, Simonetti G.

J Endovasc Ther. 2014 Oct;21(5):671-7. doi: 10.1583/14-4715MR.1.

PMID:
25290795
42.

NS5A inhibitors impair NS5A-phosphatidylinositol 4-kinase IIIα complex formation and cause a decrease of phosphatidylinositol 4-phosphate and cholesterol levels in hepatitis C virus-associated membranes.

Reghellin V, Donnici L, Fenu S, Berno V, Calabrese V, Pagani M, Abrignani S, Peri F, De Francesco R, Neddermann P.

Antimicrob Agents Chemother. 2014 Dec;58(12):7128-40. doi: 10.1128/AAC.03293-14. Epub 2014 Sep 15.

43.

IL-21 is a central memory T cell-associated cytokine that inhibits the generation of pathogenic Th1/17 effector cells.

Kastirr I, Maglie S, Paroni M, Alfen JS, Nizzoli G, Sugliano E, Crosti MC, Moro M, Steckel B, Steinfelder S, Stölzel K, Romagnani C, Botti F, Caprioli F, Pagani M, Abrignani S, Geginat J.

J Immunol. 2014 Oct 1;193(7):3322-31. doi: 10.4049/jimmunol.1400775. Epub 2014 Aug 29.

44.

Why is it so difficult to develop a hepatitis C virus preventive vaccine?

Zingaretti C, De Francesco R, Abrignani S.

Clin Microbiol Infect. 2014 May;20 Suppl 5:103-9. Epub 2013 Dec 19. Review.

45.

iNKT-cell help to B cells: a cooperative job between innate and adaptive immune responses.

Dellabona P, Abrignani S, Casorati G.

Eur J Immunol. 2014 Aug;44(8):2230-7. doi: 10.1002/eji.201344399. Epub 2014 May 30. Review.

46.

HCV E1E2-MF59 vaccine in chronic hepatitis C patients treated with PEG-IFNα2a and Ribavirin: a randomized controlled trial.

Colombatto P, Brunetto MR, Maina AM, Romagnoli V, Almasio P, Rumi MG, Ascione A, Pinzello G, Mondelli M, Muratori L, Rappuoli R, Rosa D, Houghton M, Abrignani S, Bonino F.

J Viral Hepat. 2014 Jul;21(7):458-65. doi: 10.1111/jvh.12163. Epub 2013 Aug 27. Erratum in: J Viral Hepat. 2014 Oct;21(10):751.

47.

Serum microRNAs as Biomarkers of Human Lymphocyte Activation in Health and Disease.

de Candia P, Torri A, Pagani M, Abrignani S.

Front Immunol. 2014 Feb 10;5:43. doi: 10.3389/fimmu.2014.00043. eCollection 2014. Review.

48.

Third trimester NG2-positive amniotic fluid cells are effective in improving repair in spinal cord injury.

Bottai D, Scesa G, Cigognini D, Adami R, Nicora E, Abrignani S, Di Giulio AM, Gorio A.

Exp Neurol. 2014 Apr;254:121-33. doi: 10.1016/j.expneurol.2014.01.015. Epub 2014 Jan 29.

PMID:
24485983
49.

Intracellular modulation, extracellular disposal and serum increase of MiR-150 mark lymphocyte activation.

de Candia P, Torri A, Gorletta T, Fedeli M, Bulgheroni E, Cheroni C, Marabita F, Crosti M, Moro M, Pariani E, Romanò L, Esposito S, Mosca F, Rossetti G, Rossi RL, Geginat J, Casorati G, Dellabona P, Pagani M, Abrignani S.

PLoS One. 2013 Sep 26;8(9):e75348. doi: 10.1371/journal.pone.0075348. eCollection 2013.

50.

Treatment of symptomatic high-flow female varicoceles with stop-flow foam sclerotherapy.

Gandini R, Konda D, Abrignani S, Chiocchi M, Da Ros V, Morosetti D, Simonetti G.

Cardiovasc Intervent Radiol. 2014 Oct;37(5):1259-67. doi: 10.1007/s00270-013-0760-6. Epub 2013 Nov 5.

PMID:
24190634

Supplemental Content

Loading ...
Support Center